Mesoblast Ltd Files 6-K Report with SEC
Ticker: MEOBF · Form: 6-K · Filed: Mar 27, 2024 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Mar 27, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
MESO files 6-K with SEC, standard reporting update.
AI Summary
On March 26, 2024, Mesoblast Limited filed a new release announcement with the Australian Securities Exchange. This filing is a Form 6-K report for the month of March 2024, indicating the company's ongoing reporting obligations as a foreign private issuer. Mesoblast Limited is incorporated in Australia and its CEO is Silviu Itescu.
Why It Matters
This filing provides an update on Mesoblast Limited's regulatory reporting, which is crucial for investors to stay informed about the company's compliance and operational status.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain significant new financial or operational information that would immediately impact risk.
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- March 26, 2024 (date) — Filing Date
- Australian Securities Exchange (company) — Exchange where announcement was filed
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K filing is to report information that Mesoblast Limited has made or is required to make public in Australia, as required by its home country's laws or stock exchange rules.
When was this announcement filed with the Australian Securities Exchange?
The announcement was filed with the Australian Securities Exchange on March 26, 2024.
Who is the Chief Executive Officer of Mesoblast Limited?
Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.
What is Mesoblast Limited's jurisdiction of incorporation?
Mesoblast Limited is incorporated in Australia.
Does Mesoblast Limited file an annual report on Form 20-F?
Yes, Mesoblast Limited indicates that it files annual reports under cover of Form 20-F.
Filing Stats: 213 words · 1 min read · ~1 pages · Grade level 16.9 · Accepted 2024-03-26 18:37:06
Filing Documents
- form6-kxpressreleasecoverf.htm (6-K) — 20KB
- exhibit991fdanotifiescli.htm (EX-99.1) — 8KB
- exhibit991fdanotifiescli001.jpg (GRAPHIC) — 283KB
- exhibit991fdanotifiescli002.jpg (GRAPHIC) — 170KB
- 0001345099-24-000033.txt ( ) — 653KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Paul Hughes Paul Hughes Company Secretary Dated March 27, 2024 INDEX TO EXHIBITS Item 99.1 Press release of Mesoblast Ltd, dated March 26, 2024 .